Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease.

× No keyword cloud information.

53 in total

1. Inflammatory biomarkers predict relapse in IBD.

Authors: P Hanaway; A Roseth
Journal: Gut Date: 2005-09 Impact factor: 23.059

Review 2. Role of conventional therapies in the era of biological treatment in Crohn's disease.

Authors: Paolo Gionchetti; Carlo Calabrese; Rosy Tambasco; Ramona Brugnera; Giulia Straforini; Giuseppina Liguori; Giulia Spuri Fornarini; Donatella Riso; Massimo Campieri; Fernando Rizzello
Journal: World J Gastroenterol Date: 2011-04-14 Impact factor: 5.742

Review 3. The role and utility of faecal markers in inflammatory bowel disease.

Authors: Frank S Lehmann; Emanuel Burri; Christoph Beglinger
Journal: Therap Adv Gastroenterol Date: 2015-01 Impact factor: 4.409

Review 4. Biomarkers in inflammatory bowel disease: current practices and recent advances.

Authors: Heba N Iskandar; Matthew A Ciorba
Journal: Transl Res Date: 2012-02-01 Impact factor: 7.012

5. Utility of faecal calprotectin analysis in adult inflammatory bowel disease.

Authors: Lyn A Smith; Daniel R Gaya
Journal: World J Gastroenterol Date: 2012-12-14 Impact factor: 5.742

Review 6. Mucosal healing and deep remission: what does it mean?

Authors: Gerhard Rogler; Stephan Vavricka; Alain Schoepfer; Peter L Lakatos
Journal: World J Gastroenterol Date: 2013-11-21 Impact factor: 5.742

7. Calprotectin as a diagnostic tool for inflammatory bowel diseases.

Authors: Marianthi Chatzikonstantinou; Panagiotis Konstantopoulos; Spyros Stergiopoulos; Konstantinos Kontzoglou; Christos Verikokos; Despina Perrea; Dimitris Dimitroulis
Journal: Biomed Rep Date: 2016-09-07

8. Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease.

Authors: Michael Wagner; Christer G B Peterson; Peter Ridefelt; Per Sangfelt; Marie Carlson
Journal: World J Gastroenterol Date: 2008-09-28 Impact factor: 5.742

9. Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes.

Authors: Andrea Vieira; Chia Bin Fang; Ernani Geraldo Rolim; Wilmar Artur Klug; Flávio Steinwurz; Lucio Giovanni Battista Rossini; Paulo Azevedo Candelária
Journal: BMC Res Notes Date: 2009-10-29

10. Cancer antigen 125 levels in inflammatory bowel diseases.

Authors: Hilmi Ataseven; Zeynel Abidin Oztürk; Mehmet Arhan; Osman Yüksel; Seyfettin Köklü; Mehmet Ibiş; Omer Başar; Fatma Meriç Yilmaz; Ilhami Yüksel
Journal: J Clin Lab Anal Date: 2009 Impact factor: 2.352